News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
264,463 Results
Type
Article (14095)
Company Profile (282)
Press Release (250086)
Section
Business (79449)
Career Advice (152)
Deals (13217)
Drug Delivery (35)
Drug Development (50397)
Employer Resources (31)
FDA (5703)
Job Trends (5125)
News (144285)
Policy (10024)
Tag
Academia (905)
Alliances (21604)
Alzheimer's disease (796)
Antibody-drug conjugate (ADC) (75)
Approvals (5705)
Artificial intelligence (93)
Bankruptcy (102)
Best Places to Work (4561)
Biotechnology (232)
Breast cancer (130)
Cancer (1112)
Cardiovascular disease (88)
Career advice (132)
CAR-T (92)
Cell therapy (272)
Clinical research (40556)
Collaboration (436)
Compensation (184)
COVID-19 (1024)
C-suite (117)
Cystic fibrosis (74)
Data (1150)
Diabetes (105)
Diagnostics (1278)
Earnings (29209)
Events (47650)
Executive appointments (353)
FDA (6209)
Funding (414)
Gene editing (76)
Gene therapy (197)
GLP-1 (338)
Government (1071)
Healthcare (6568)
Infectious disease (1075)
Inflammatory bowel disease (105)
IPO (7247)
Job creations (859)
Job search strategy (127)
Layoffs (196)
Legal (1383)
Lung cancer (164)
Manufacturing (103)
Medical device (2576)
Medtech (2577)
Mergers & acquisitions (6203)
Metabolic disorders (315)
Neuroscience (1108)
NextGen: Class of 2025 (2012)
Non-profit (852)
Northern California (1339)
Obesity (166)
Opinion (96)
Parkinson's disease (89)
Patents (86)
People (25352)
Phase I (14313)
Phase II (18872)
Phase III (11921)
Pipeline (504)
Postmarket research (852)
Preclinical (5996)
Radiopharmaceuticals (209)
Rare diseases (247)
Real estate (1414)
Regulatory (8438)
Research institute (932)
Series A (82)
Southern California (1188)
Startups (1968)
United States (10528)
Vaccines (189)
Weight loss (96)
Date
Today (91)
Last 7 days (360)
Last 30 days (1590)
Last 365 days (20459)
2025 (2637)
2024 (20552)
2023 (22414)
2022 (26823)
2021 (27808)
2020 (23356)
2019 (16223)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (148)
Asia (17095)
Australia (2893)
California (3047)
Canada (965)
China (269)
Colorado (115)
Connecticut (130)
Delaware (72)
Europe (36776)
Florida (348)
Georgia (91)
Illinois (192)
Indiana (73)
Maryland (396)
Massachusetts (2383)
Minnesota (119)
New Jersey (761)
New York (835)
North Carolina (475)
Northern California (1339)
Ohio (98)
Pennsylvania (576)
South America (207)
Southern California (1188)
Texas (337)
Washington State (291)
264,463 Results for "pinetree therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Pinetree Therapeutics Announces Exclusive Option and Global License Agreement for Preclinical EGFR Degrader Candidate with AstraZeneca
July 23, 2024
·
2 min read
Press Releases
Pinetree Therapeutics Closes $17 Million in Series A Funding to Advance AbReptor™ Protein Degradation Platform and Portfolio Programs
July 30, 2024
·
3 min read
Business
Pinetree Therapeutics Announces Two Appointments to Strengthen its Scientific Leadership
Pinetree Therapeutics, Inc. announced the addition of Pamela A. Trail, PhD, to its Scientific Advisory Board as well as the appointment of John Majercak, PhD, as Chief Technology Officer.
May 31, 2023
·
3 min read
Genetown
PineTree Therapeutics Receives a Bits and Bytes Grant from Massachusetts Life Sciences Center
PineTree Therapeutics and Professors Jason Evans and Nurit Haspel at University of Massachusetts Boston have received capital funding this summer from the Massachusetts Life Sciences Center Bits and Bytes program to accelerate the efforts of PineTree Therapeutics’ next generation biotherapeutics development.
September 27, 2022
·
2 min read
Genetown
PineTree Therapeutics, Inc. Secures $23.5 Million of Series A1 Funding to Develop Cutting Edge Platform Technology to Create Therapeutic Assets for Unmet Medical Needs
PineTree Therapeutics, Inc., an emerging leader in pioneering the development of disruptive therapies in Oncology, Immuno-oncology and other diseases, announced that the company has raised $23.5 Million for Series A1 funding.
June 7, 2022
·
3 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Tango Therapeutics to Present at Three Upcoming Investment Bank Conferences
February 20, 2025
·
1 min read
Press Releases
MiNK Therapeutics Regains Full Compliance with Nasdaq Listing Requirements
February 20, 2025
·
1 min read
Press Releases
Allogene Therapeutics Announces Participation in February Investor Conferences
February 4, 2025
·
2 min read
Press Releases
Denali Therapeutics Announces Upcoming Presentations on Hunter Syndrome (MPS II) and TransportVehicle™ Enabled Investigational Therapeutic Tividenofusp Alfa at the 2025 WORLDSymposium™
January 30, 2025
·
4 min read
1 of 26,447
Next
